SHC 0.00% 2.5¢ sunshine heart, inc.

short term potential catalysts , page-29

  1. 33 Posts.
    I am puzzled and frustrated at the price action on SSH - and I know I'm not alone. Six months ago, looking at the upcoming catalysts at that time, I was sure that SSH would be in the range of $15 by now.

    I think the data for C-Pulse has yet to reach the critical mass needed to convince most investors that the device works as advertised. We're still essentially looking at a small set of very positive data from the feasibility trial. The slow progress on the current large scale FDA trial is prolonging the wait for "proof".

    The slow pace of enrolment is a temporary hurdle, not a true risk factor. Once there are enough success stories for C-Pulse to show the feasibility results were not a fluke, SSH will take off.

    I just hope the stock rebounds and that there is some good news soon! I'm in for the long haul, in any case. But it would be a lot easier if SSH moves in the right direction while we all wait.

 
watchlist Created with Sketch. Add SHC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.